Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

George Diaz, MD, FIDSA (he/him/his)

Chief of Medicine
Providence Regional Medical Center Everett
Edmonds, WA, United States

Dr. Diaz completed his medical residency and also served as a Chief Medical Resident at the University of Utah. He has been practicing Infectious Diseases at Providence Regional Medical Center Everett (PRMCE) since completing his training in Infectious Diseases at the University of Washington in 2005. His clinical prarice is as a hospital-based Infectious Diseases provider. He is the Chief of Medicine and Medical Director of Antimicrobial Stewardship and Infection Prevention at PRMCE. He also works for Providence St. Joseph Health as a System Provider Informaticist, which focuses on improving the Infectious Diseases care of patients by improving the electronic medical record. He provides service to the Infectious Diseases Society of America as a spokesman and member of the AMS subcommittee. He is a also former member of the Clinical Affairs Committee. He also serves as a member of the Epic Infectious Diseases Steering Board (based in Wisconsin). He has an appointment as Clinical Professor in the Washington State University College of Medicine. His teaching assignments include 4th year medical student Infectious Diseases clerkship, and serving as a Specialty Education Coordinator for the WSU Internal Medicine Residency Program based at PRMCE.. He has been a principal investigator on multiple clinical trials for COVID therapeutics. He has been an co-author on 3 publications in the New England Journal of Medicine in the use of Remdesivir for COVID-19 and first author in JAMA describing myocarditis and pericarditis after COVID-19 vaccination.

Disclosure(s): edesa: Grant/Research Support (Terminated, July 1, 2023); Genetech/Roche: Grant/Research Support (Terminated, July 1, 2023); giliead: Grant/Research Support (Terminated, July 1, 2023); NIH: Grant/Research Support (Terminated, March 1, 2024); Regeneron, Inc: Grant/Research Support (Terminated, January 1, 2023)

Presentation(s):